bioAffinity Technologies (BIAFW) Projected to Post Quarterly Earnings on Monday

bioAffinity Technologies (NASDAQ:BIAFW) is projected to post its resultson Monday, April 6th. Analysts expect bioAffinity Technologies to post earnings of ($2.70) per share and revenue of $1.5530 million for the quarter.

bioAffinity Technologies Stock Down 6.9%

Shares of BIAFW stock opened at $0.36 on Friday. The stock has a fifty day moving average price of $0.30 and a 200 day moving average price of $0.31. bioAffinity Technologies has a one year low of $0.05 and a one year high of $0.81.

About bioAffinity Technologies

bioAffinity Technologies, Inc is a clinical-stage medical device company developing an extracorporeal immunoadsorption platform intended to treat Gram-negative sepsis and other severe inflammatory conditions. The company’s technology employs specialized sorbent cartridges designed to selectively bind and remove circulating endotoxins and inflammatory mediators from the bloodstream, with the goal of supporting critical care interventions and improving patient outcomes.

In preclinical studies, bioAffinity’s hemoperfusion devices have demonstrated the ability to capture lipopolysaccharides released by Gram-negative bacteria, leading to reductions in pro-inflammatory cytokines and enhanced survival rates in animal models.